Filing Details
- Accession Number:
- 0000930413-18-000097
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-19 16:42:46
- Reporting Period:
- 2018-01-17
- Accepted Time:
- 2018-01-19 16:42:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 316253 | Enzo Biochem Inc | ENZ | Services-Medical Laboratories (8071) | 132866202 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 903568 | Elazar Rabbani | C/O Enzo Biochem, Inc. 527 Madison Avenue New York NY 10022 | Ceo, Chn. Of The Brd. And Sec. | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-17 | 38,505 | $2.88 | 1,867,202 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-17 | 14,000 | $7.75 | 1,853,202 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-17 | 14,534 | $7.75 | 1,838,668 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (to acquire common stock) | Disposition | 2018-01-17 | 38,505 | $0.00 | 38,505 | $2.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 222,249 | 2014-01-17 | 2018-01-17 | No | 4 | M | Direct |
Footnotes
- Represents shares sold to satisfy reporting person's tax obligations.
- Represents shares withheld by the company to cover the exercise price of the Stock Options.
- The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.70 to $7.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
